- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Cetuximab – November 2016
Cetuximab: Injection 100 mg in 20 mL, Injection 500 mg in 100 mL; Erbitux®
Last updated
3 March 2017